R R

What Is Orencia?

Orencia is a prescription biologic medication containing abatacept, a selective T-cell costimulation modulator. It is approved for adults with moderately to severely active rheumatoid arthritis and patients aged two years and older with certain forms of juvenile idiopathic arthritis or psoriatic arthritis. Orencia is also used with other medications to prevent acute graft-versus-host disease in specified stem cell transplant recipients. It is administered by intravenous infusion or subcutaneous injection, depending on the indication. Orencia helps control immune activity but does not cure inflammatory arthritis.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Orencia?

Orencia is a prescription biologic medication containing abatacept, a selective T-cell costimulation modulator. It is approved for adults with moderately to severely active rheumatoid arthritis and patients aged two years and older with certain forms of juvenile idiopathic arthritis or psoriatic arthritis. Orencia is also used with other medications to prevent acute graft-versus-host disease in specified stem cell transplant recipients. It is administered by intravenous infusion or subcutaneous injection, depending on the indication. Orencia helps control immune activity but does not cure inflammatory arthritis.

read more about orencia ...

Copy this HTML:

Copy HTML Copied!

How Does Orencia Work?

Orencia interferes with the activation of T lymphocytes, immune cells involved in inflammatory responses. Abatacept binds to CD80 and CD86 proteins on antigen-presenting cells, preventing their interaction with CD28 receptors on T cells. This interrupts a signal required for full T-cell activation. By reducing immune activity, Orencia helps decrease inflammation associated with rheumatoid arthritis and other approved inflammatory conditions. Its mechanism differs from medications that block tumor necrosis factor. Reduced immune activity can also increase susceptibility to infections.

What Conditions Does Orencia Treat?

Orencia is approved for moderately to severely active rheumatoid arthritis in adults, moderately to severely active polyarticular juvenile idiopathic arthritis in patients aged two years and older, and active psoriatic arthritis in patients aged two years and older. It is also approved with a calcineurin inhibitor and methotrexate to prevent acute graft-versus-host disease in certain patients undergoing unrelated-donor hematopoietic stem cell transplantation. Treatment selection depends on the diagnosis, age, prior therapies, and infection history. Approved administration routes differ by condition and patient age.

How Is Orencia Administered?

Orencia can be administered through an intravenous infusion or a subcutaneous injection. Adults receiving intravenous treatment for rheumatoid arthritis or psoriatic arthritis commonly receive weight-based doses at the beginning of treatment, two weeks later, four weeks later, and every four weeks afterward. Adults receiving subcutaneous treatment for rheumatoid arthritis commonly use 125 mg once weekly. Pediatric dosing depends on weight, age, diagnosis, and formulation. Graft-versus-host disease prevention follows a separate intravenous schedule. Patients should receive instructions for the prescribed formulation and complete recommended infection screening before treatment.

What Are the Side Effects and Warnings of Orencia?

Common adverse effects include headache, nausea, upper respiratory infections, and inflammation of the nose and throat. Serious risks include severe infections, allergic reactions, and reactivation of certain infections. Patients should undergo screening for tuberculosis and viral hepatitis before treatment. Orencia can reduce vaccine responses, and live vaccines should generally be avoided during treatment and for three months after discontinuation. Patients with chronic obstructive pulmonary disease can experience additional respiratory complications. New fever, persistent coughing, or breathing difficulties require medical evaluation.

Common Questions About Orencia

Is Orencia a biologic medication?

Yes. Orencia contains abatacept, a biologic medication that reduces T-cell activation and helps control inflammation in certain immune-mediated conditions.

Can Orencia treat rheumatoid arthritis?

Yes. Orencia is approved for adults with moderately to severely active rheumatoid arthritis. It can reduce inflammatory symptoms and disease activity.

How often is Orencia administered?

Intravenous maintenance treatment for adult rheumatoid arthritis is generally administered every four weeks after initial doses. Subcutaneous treatment is commonly given once weekly. Schedules differ by indication and age.

Does Orencia increase infection risk?

Yes. Orencia changes immune activity and can increase susceptibility to infections, including serious infections. Screening and monitoring are necessary during treatment.

References

Abatacept. LiverTox. https://www.ncbi.nlm.nih.gov/books/NBK548442/. Date Accessed October 22, 2026.

Abatacept. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Abatacept. Date Accessed October 22, 2026.

Abatacept Injection. MedlinePlus. https://medlineplus.gov/druginfo/meds/a606016.html. Date Accessed October 22, 2026.

DailyMed - ORENCIA (abatacept) injection. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0836c6ac-ee37-5640-2fed-a3185a0b16eb. Date Accessed October 22, 2026.

Orencia. European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/orencia. Date Accessed October 22, 2026.